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Abstract
Mesenchymal stem cells (MSCs) can differentiate toward epithelial cells and may be used as an alternative 
source for generation of heterotypical artificial human skin substitutes, thus, enhancing their development and 
translation potential to the clinic. The present study aimed at comparing four types of heterotypical human 
bioengineered skin generated using MSCs as an alternative epithelial cell source. Adipose-tissue-derived 
stem cells (ADSCs), dental pulp stem cells (DPSCs), Wharton’s jelly stem cells (WJSCs) and bone marrow 
stem cells (BMSCs) were used for epidermal regeneration on top of dermal skin substitutes. Heterotypic 
human skin substitutes were evaluated before and after implantation in immune-deficient athymic mice for 
30 d. Histological and genetic studies were performed to evaluate extracellular matrix synthesis, epidermal 
differentiation and human leukocyte antigen (HLA) molecule expression. The four cell types differentiated into 
keratinocytes, as shown by the expression of cytokeratin 10 and filaggrin 30 d post-grafting; also, they induced 
dermal fibroblasts responsible for the synthesis of extracellular fibrillar and non-fibrillar components, in a 
similar way among each other. WJSCs and BMSCs showed higher expression of cytokeratin 10 and filaggrin, 
suggesting these cells were more prone to epidermal regeneration. The absence of HLA molecules, even 
when the epithelial layer was differentiated, supports the future clinical use of these substitutes – especially 
ADSCs, DPSCs and WJSCs – with low rejection risk. MSCs allowed the generation of bioengineered human 
skin substitutes with potential clinical usefulness. According to their epidermal differentiation potential and 
lack of HLA antigens, WJSCs should preferentially be used.
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Introduction
In recent years, tissue engineering has developed 
as an alternative regenerative medicine approach 
for the clinical treatment of severe skin diseases, as 
it allows the efficient treatment of large and deep 
skin conditions (Garzon et al., 2015; Kober et al., 
2016). Numerous models of human skin, generated 
by tissue engineering, have been developed to date 
(Beaudoin Cloutier et al., 2017; Bhowmick et al., 2017; 
Forouzandeh et al., 2010; Hartmann-Fritsch et al., 
2016; Klar et al., 2018; Larouche et al., 2016; Lloyd et al., 
2015; Pensalfini et al., 2017; Reuter et al., 2017; Strong et 
al., 2017; Vig et al., 2017). However, few clinical trials 
have been conducted to test the biological security 
(phase I and II assays) of human skin models (Boa et 
al., 2013; Boyce et al., 2006; Boyce et al., 1999; Boyce 
et al., 2017; Germain et al., 2018; Moravvej et al., 2016; 
Yamada et al., 2012). Most of the clinically efficient 
skin models are organotypic structures, consisting of 
a dermal substitute of dermal fibroblasts immersed 
in biocompatible scaffolds and an epidermal layer 
of keratinocytes seeded on top of the stroma. 
These orthotypic models show high feasibility for 
epidermal differentiation and maturation because 
differentiation of epidermal cells strongly depends 
on epithelial-mesenchymal interactions (Smola et 
al., 1993).
 Development of organotypic human skin 
substitutes is strongly dependent on the isolation and 
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culture of autologous cells, isolated and expanded in 
culture from healthy donor skin. However, healthy 
skin biopsies are sometimes difficult to obtain, 
especially when the patient is in a critical condition 
due to large-scale burns and concomitant infections. 
In addition, a major limitation of this technique is 
the time required for the isolated cells to generate 
a sufficient number of cells for tissue engineering, 
especially in the case of keratinocytes. On the 
other hand, epidermal keratinocytes are terminally 
differentiated cells that are difficult to handle in 
culture in the absence of feeder layers, proliferate 
slowly and tend to dedifferentiate in culture (Garzon 
et al., 2015; Kraft et al., 2012). For all these reasons, 
alternative cell sources allowing for the generation 
of human skin substitutes, without the drawbacks 
associated with skin biopsies, are needed for an 
optimal clinical translation (Bhardwaj et al., 2017).
 Mesenchymal stem cells (MSCs) are adult cells 
with proliferation and differentiation capabilities, 
showing adherence to plastic, expression of specific 
surface markers and multipotent differentiation 
potential into adipocyte, chondrocyte and osteoblast 
lineages (Dominici et al., 2006; Kim and Park, 2017; 
Pittenger et al., 1999). MSCs are excellent candidates 
for tissue engineering applications due to their 
unique properties. MSCs have been described in a 
wide variety of human adult tissues (Gimble and 
Guilak, 2003). However, the four main sources of 
MSCs in humans are adipose-tissue-derived stem 
cells (ADSCs) (Zuk et al., 2002), dental pulp stem 
cells (DPSCs) (Gronthos et al., 2000), umbilical 
cord Wharton’s jelly stem cells (WJSCs) (Wang et 
al., 2004) and bone marrow stem cells (BMSCs) 
(Friedenstein et al., 1976; Pittenger et al., 1999). In 
addition to adipocyte, chondrocyte and osteoblast 
differentiation potential, MSCs have epithelial 
differentiation capability and heterotypical models 
of artificial tissues could be generated using MSCs 
as alternative cell sources (Garzon et al., 2013). In this 
regard, preliminary reports support the epithelial 
differentiation capability of ADSCs (Baer et al., 2013) 
and human tooth-derived stem cells (Dogan et al., 
2015). In turn, WJSCs are efficiently differentiated into 
cornea epithelial cells (Garzon et al., 2014) and human 
skin as well as oral mucosa keratinocytes (Garzon et 
al., 2013). BMSCs, the most characterised MSC source, 
can differentiate into several types of epithelial 
cells, including skin keratinocytes (Kokubun et al., 
2016; Mahdavishahri et al., 2012; Mendez et al., 2014; 
Wang et al., 2014; Zhang et al., 2012). Although these 
previous reports support the epithelial potential 
of MSCs, there are no studies comparing the 
keratinocytic differentiation capability of the four 
main MSC sources for skin tissue engineering.
 When compared with skin keratinocyte cultures, 
MSCs have important advantages, including 
accessibility, high proliferation rate and easy 
culturing, as well as very low risk of malignant 
transformation after allogeneic transplantation as 
compared to embryonic stem cells (ESCs) or induced 
pluripotent stem cells (iPS) (Kim and Park, 2017). 
In addition, one of the striking properties of MSCs, 
from a translational point of view, is that these cells 
are immunoprivileged due to the low expression of 
human leukocyte antigen (HLA) complex molecules 
and may have immunomodulatory properties 
(Castro-Manrreza and Montesinos, 2015; Losk 
et al., 2016; Shi et al., 2011). Several studies have 
demonstrated that MSCs can be grafted into a host 
patient with a low rejection risk (Casiraghi et al., 2008; 
Ma et al., 2017; Reinders et al., 2013). In this sense, 
development of human skin models using allogeneic 
MSCs differentiated into epidermal keratinocytes 
could prevent the above-described shortcomings 
derived from generation of autologous skin models. 
Thus, easier and faster generation of heterotypical 
models could be an advantageous approach for the 
translation of these advanced-therapy products as a 
therapeutical choice.
 The aim of the present study was to compare 
four different models of heterotypical human 
bioengineered skin generated by using ADSCs, 
DPSCs, WJSCs and BMSCs as alternative epithelial 
cell sources. These models were evaluated in vitro or 
in vivo to determine the potential clinical usefulness 
of heterotypical human skin substitutes.
Materials and Methods
Generation of MSC primary cell cultures
To generate primary cell cultures of human dermis 
fibroblasts, skin biopsies were obtained from healthy 
donors. To generate primary cultures of ADSCs, 
WJSCs and BMSCs, small biopsies were obtained 
from adipose tissue, umbilical cord and bone marrow, 
as previously described (Alfonso-Rodriguez et al., 
2015; Cejka et al., 2016; Dori et al., 2017). To generate 
DPSC cultures, extracted sound third molars were 
obtained (Garzon et al., 2017). In all cases, tissues 
were obtained from healthy donors subjected to 
surgical procedures not related to the present study. 
All patients gave informed consent and the study 
was approved by the Research and Ethics Committee 
of the Health System of Granada Hospitals, Spain.
 Upon arrival at the laboratory, tissues were 
washed in phosphate-buffered saline (PBS), dissected 
to isolate tissues rich in MSCs and enzymatically 
digested for 6 h at 37 °C under slight agitation 
with a 2 mg/mL solution of Clostridium histolyticum 
type I collagenase (Gibco). Isolated human dermal 
fibroblasts and ADSCs, DPSCs and BMSCs were 
cultured in Dulbecco’s modified Eagle’s medium 
(DMEM; Sigma-Aldrich) supplemented with 10 % 
foetal bovine serum (Sigma-Aldrich) and 1 % antibiotic 
and antimycotics (100 U/mL penicillin G, 100 mg/
mL streptomycin and 0.25 mg/mL anphoterycin B; 
Sigma-Aldrich) under standard culture conditions. 
WJSCs were cultured in AmnioMAX™ medium 
(Gibco), as previously reported (Alfonso-Rodriguez 
et al., 2015). Culture medium was changed three 
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times a week and cells were dissociated with 0.25 % 
trypsin-ethylenediaminetetraacetic acid (EDTA; 
Sigma-Aldrich) before reaching confluence.
Generation of human heterotypic skin (HHS)
HHS was developed using 24 mm Transwell® porous 
inserts with polycarbonate membranes with a pore 
size of 0.4 µm (Costar, Corning Inc.). Briefly, a stromal 
substitute was generated using a mixture of human 
fibrin obtained from frozen plasma (Human Tissue 
Bank of Granada, Spain) and 0.1 % type VII agarose 
in PBS. To produce a 5 mL dermal substitute, 3.8 mL 
of human plasma were added to 375 µL of DMEM 
with 500,000 cultured skin fibroblasts. To prevent 
gel fibrinolysis, the mixture was supplemented 
with 75 µL of tranexamic acid (Amchafibrin, Fides 
Ecopharma, Barcelona, Spain). Then, 500 µL of 1 % 
CaCl2 were added to induce fibrin polymerisation, 
followed by immediate addition of 250 µL of 
melted concentrated agarose (2 % in PBS) at 40 °C. 
The final concentration of agarose in the stromal 
substitute was 0.1 %. Finally, the mixture was rapidly 
aliquoted on porous inserts and allowed to solidify 
at 37 °C for 2 h. 24 h after the stroma had solidified, 
250,000 MSCs were seeded on top of the stromal 
layer to generate an epithelial-like layer consisting 
of each MSC type in order to generate ADSC-HHS, 
DPSC-HHS, WJSC-HHS and BMSC-HHS substitutes. 
All HHS were cultured for 7 d submerged in culture 
medium and cultured for 21 d following an air-
liquid culture technique (Garzon et al., 2014) to 
induce epithelial differentiation (4 weeks in total). 
Heterotypic artificial skin substitutes were cultured 
in keratinocyte inductive medium consisting of a 3 : 1 
mixture of DMEM and HAM’s F12 culture medium 
supplemented with 10 % foetal bovine serum (FBS), 
1 % antibiotic/antimycotic solution, 24 µg/mL 
adenine, 0.4 µg/mL hydrocortisone, 5 µg/mL insulin, 
10 ng/µL epidermal growth factor and 1.3 ng/mL 
triiodothyronine (all reagents were purchased from 
Sigma-Aldrich).
In vivo evaluation
To evaluate them in vivo, HHS were grafted in 6-week-
old immune-deficient athymic nude Foxn1nu mice 
(Envigo, Huntingdon, UK) (Fig. 1). Briefly, mice were 
anesthetised using a mixture of 0.001 mg/g of body-
weight of acepromazine (Calmo-Neosan, Boehringer 
Ingelheim, Ingelheim am Rhein, Germany) and 
0.15 mg/g of body-weight of ketamine (Imalgene 
1000, Merial labs, Barcelona, Spain). Then, a skin 
area of 20 mm in diameter was surgically removed 
from the dorsal area of each animal and the HHS was 
trimmed to the same diameter. HHS samples were 
grafted at the injury site using absorbable suture 
material. A plastic ring was implanted at the injury 
borders and sutured using the same suture material 
to prevent the host skin from shrinking; the plastic 
ring was carefully removed after 10 d post-grafting. 
Only one graft HHS was implanted per mouse. Mice 
were euthanised 15 or 30 d after implantation of the 
bioengineered tissues, for histological analysis of 
grafted HHS and surrounding native skin. 4 mice 
per MSC group (ADSCs, DPSCs, WJSCs and BMSCs) 
were used.
Histological analyses
Control native human skin (NHS) and HHS kept in 
vitro (for 1, 2 and 4 weeks) and grafted in vivo (for 15 
and 30 d) were fixed in 4 % formaldehyde for 24 h 
at 4 °C and embedded in paraffin. 5 µm-thick tissue 
sections were stained with haematoxylin-eosin for 
histological analysis. 5 independent sample replicates 
were analysed per group.
 To evaluate the synthesis of extracellular matrix 
(ECM) components in the bioengineered dermis, 
the presence of collagen fibres, glycosaminoglycans 
(GAGs) and proteoglycans was assessed by 
histochemistry. First, the presence of collagen fibres 
was evaluated by picrosirius red histochemistry 
using Sirius red F3B (Sigma-Aldrich) for 30 min, 
as previously described (Alfonso-Rodriguez et 
al., 2014). Fibre organisation was assessed by 
polarised light microscopy. To identify the presence 
of glycoproteins in the HHS, the Schiff periodic 
acid histochemical method (PAS), with Harris’s 
haematoxylin counterstaining for 1 min, was used. 
Finally, samples were incubated in alcian blue 
histochemical solution for 30 min and counterstained 
with nuclear fast red solution for the detection of 
extracellular proteoglycans (Alfonso-Rodriguez et 
al., 2014).
 Epithelial layer analysis was performed by 
immunofluorescence for the epidermal markers 
cytokeratin 5 (CK5), cytokeratin 10 (CK10) and 
filaggrin (FGN). Briefly, tissue sections were 
deparaffinised and rehydrated before antigen retrieval 
with citrate buffer for 20 min at 95 °C. Then, samples 
were prehybridised with normal horse serum (Vector 
Laboratories) for 1 h and incubated with prediluted 
anti-CK5 and anti-CK10 (Master Diagnostica, 
Granada, Spain) or 1 : 50 anti-FGN (Abcam) primary 
Fig. 1. Generation of heterotypical bioartificial human skin substitutes by tissue engineering and surgical 
grafting in animal models for in vivo evaluation. 
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antibodies overnight at 4 °C. Anti-mouse secondary 
antibodies conjugated with fluorescein isothiocyanate 
(FITC; Sigma-Aldrich) were used at a 1 : 500 dilution. 
Sections were counterstained with mounting medium 
containing 4′,6-diamidino-2-phenylindole (DAPI; 
Vector Laboratories).
 To identify the presence of major histocompatibility 
complex molecules, routine immunohistochemical 
methods were used. First, samples were dewaxed 
and rehydrated and endogenous peroxidase 
was quenched with H2O2. Then, tissues were 
prehybridised and incubated with primary antibodies 
against type I HLA (HLA I) and type II HLA (HLA 
II) diluted at 1 : 200 (Santa Cruz Biotech). Positive 
signal was visualised using 3, 3-diaminobenzidine 
(DAB; Vector Laboratories) and tissue sections were 
counterstained for 15 s with Harris’s haematoxylin.
 In all cases, light microscopy images were obtained 
using an Eclipse 90i microscope (Nikon). Results 
of the histochemical and immunohistochemical 
analyses were semi-quantitatively analysed as 
previously described (Garzon et al., 2014; Garzon et 
al., 2009b). Staining was categorised as strong (+++), 
mild (++), slight (+) or negative (−). The expression 
was also stated following the topograpycal location 
of the signal as basal layer (a), spinosum layer (b), 
granulosum layer (c), cornified layer (d) or all layers 
(e). In all cases, average results corresponding to the 
analysis of 5 replicate samples were obtained.
Preliminary gene expression analysis
To determine the putative differentiation potential 
of each MSC type, ADSCs, DPSCs, WJSCs and 
BMSCs were kept in culture in basal medium 
(DMEM supplemented with 10 % foetal calf 
serum and antibiotics-antimycotics) or epithelial 
induction medium (QC) for 28 d. Then, total RNA 
was isolated from each cell culture using RNeasy 
Mini Kit (Qiagen) and retrotranscribed to cDNA 
using a reverse transcriptase (Superscript II, Life 
Technologies) and a T7-oligo(dT) primer. Biotinylated 
cRNA was generated using a T7 RNA polymerase and 
biotin-11-uridine-5’-triphosphate (Enzo Diagnostics, 
Farmingdale, NY, USA), chemically fragmented and 
hybridised to Affymetrix Human Genome U133 
plus 2.0 oligonucleotide arrays (Affymetrix Inc., 
Santa Clara, CA, USA) for 6 h at 45 °C. 4 samples 
were analysed per group (n = 4). Expression levels 
found for each probe-set in the array were classified 
as present (P), marginal (M) or absent (A) for each 
sample by using the Affymetrix Suite software 
(Affymetrix Inc.). Affymetrix NetAffx Analysis Center 
(Affymetrix Inc.) was used to identify all genes in the 
array with a putative epithelial-cell-related function. 
All probe-sets showing an expression increase after 
QC induction (for example, an absent gene in cells 
cultured with basal medium that became present 
upon QC culturing) were selected for each MSC type. 
To determine the gene functions associated with 
Fig. 2. Haematoxylin and eosin histological analysis of NHS and HHS generated using ADSCs, DPSCs, 
WJSCs and BMSCs kept in vitro for 1, 2 and 4 weeks and grafted in vivo for 15 and 30 d. Scale bar: 200 µm. 
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selected probe-sets, BiNGO gene ontology analysis 
(Ghent University, Belgium) was used as previously 
described (Maere et al., 2005).
Results
Gene expression analysis
Preliminary gene expression analysis suggested that 
QC differentiation medium induced the expression of 
several genes in the 4 MSC types evaluated (Raw Data 
file 1). Out of the 54,613 array probe-sets, 4,351 (7.97 % 
of all probe-sets) became upregulated upon induction 
in ADSCs, with 172 being identified as epithelial 
genes. For WJSCs, 3,670 probe-sets (6.72 %) were 
upregulated, with 184 corresponding to epithelial 
genes. When BMSCs were analysed, 2,913 probe-sets 
(5.33 %) were upregulated, with 103 being identified 
as epithelial genes. Finally, 2,545 probe-sets (4.66 %) 
were upregulated in DPSCs, with 106 corresponding 
to epithelial genes. BiNGO gene ontology analysis 
identified 98 gene functions associated with all 
probe-sets activated in ADSCs, 76 in WJSCs and 23 
in BMSCs and DPSCs (Raw Data 2 file). Although 
most ‘GO’ gene functions corresponded to unspecific 
cell components and cell physiology, some of these 
functions were associated with cell adhesion and 
cell-cell junctions.
In vitro and in vivo histological analysis
In vitro generation of HHS substitutes using 
ADSCs, DPSCs, WJSCs and BMSCs allowed for the 
development of an epithelial-like layer from the first 
week of culture in all study groups (Fig. 2). HHS 
generated using transdifferentiated ADSCs and 
DPSCs were able to form an epithelium-like structure 
composed of a single cell layer along the 4 weeks 
of in vitro culture without any sign of terminal 
differentiation.
 Grafting of HHS for the treatment of skin wounds 
did not generate any signs of inflammation, necrosis or 
other harmful effects. After 15 d post-grafting, wound 
diameter showed an average contraction of 45 % as 
compared to the original injury for all experimental 
groups and 61.7 % after 30 d (Fig. 1). However, 
after in vivo grafting, both cell populations induced 
the generation of up to 10 epithelial-like layers 
after 15 and 30 d. Haematoxylin-eosin histological 
Fig. 3. Analysis of the epithelial surface of NHS and HHS generated using ADSCs, DPSCs, WJSCs and 
BMSCs kept in vitro for 1, 2 and 4 weeks and grafted in vivo for 15 and 30 d.
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staining revealed the presence of basal, spinosum, 
granulosum and cornified strata both in ADSCs and 
DPSCs once grafted in vivo, being similar to NHS. 
In addition, non-dermal papillae and epithelial rete 
ridges were identified in vitro or in vivo. When WJSCs 
and BMSCs were used as epithelial substitutes, a 
single layer was observed after 1 week in vitro. In 
contrast, after 14 d, the epithelial-like tissue formed 
more than 2 layers. The number of formed layers was 
time-dependent, with the identification of more than 
6 layers after 28 d in both WJSCs and BMSCs, more 
being formed when WJSCs were used. Strikingly, all 
cell layers were morphologically similar and no signs 
of stratum differentiation were found in vitro. After 
in vivo implantation, epithelial cells showed a high 
degree of organisation and differentiation in basal, 
spinosum, granulosum and cornified strata, as in the 
case of NHS, although rete ridges and dermal papillae 
were not identified. The analysis of the epithelial 
surface of the different HHS, as determined by 
scanning electron microscopy (SEM), demonstrated 
that the MSCs used as epithelial-like substitute 
in vitro had the typical spindle-shape, elongated 
morphology of native MSCs (Fig. 3). However, cells 
tended to partially change their morphology and 
acquire a more polygonal shape with time in culture, 
especially in the case of WJSCs and BMSCs at day 28. 
Once grafted in vivo, the four MSC types showed a 
clear morphological change and cells became clearly 
flat and polygonal, showing keratinisation and 
desquamation signs, especially after 30 d of in vivo 
development.
In vitro and in vivo evaluation of the dermal 
substitute
The dermal substitute was mainly composed of 
cellular and extracellular components. A spindle-
shape cell population was found in all in vitro HHS 
substitutes and the cell number tended to increase 
once grafted in vivo (Fig. 2).
 The ECM is mainly composed of fibrillar and non-
fibrillar molecules. In terms of fibrillar components, 
collagen fibres were identified by picrosirius red 
staining (Fig. 4, Table 1). In vitro development did 
not show any sign of mature collagen synthesis 
in ADSC, DPSC, WJSC or BMSC HHS samples. 
However, in vivo grafting resulted in the expression 
of collagen fibres, mainly in WJSCs after 15 d and in 
DPSCs, WJSCs and BMSCs after 30 d, with similar 
amount and fibre organisation as compared to NHS. 
However, ADSCs showed mild expression of collagen 
from day 15.
 Regarding the non-fibrillar components of ECM, 
GAGs staining by PAS was negative in all in vitro 
samples. Furthermore, in vivo implantation of HHS 
using MSCs resulted in mildly positive expression 
of GAGs at 30 d in DPSC, WJSC and BMSC HHS 
and positive signal in ADSC HHS at the basement 
membrane. Interestingly, the staining signal found 
in ADSCs corresponding to day 30 was comparable 
to that of NHS (Fig. 5, Table 1).
 Alcian blue staining detected proteoglycans as 
other important non-fibrillar components of the ECM 
(Fig. 6, Table 1). In this sense, in vitro development 
of HHS resulted in a lack of expression of these 
molecules. Once HHS samples were implanted in 
an animal model, proteoglycans synthesis reached 
intermediate levels of expression in ADSCs, DPSCs 
and WJSCs after 15 d. BMSCs revealed stronger 
synthesis with similar levels to NHS after 15 d. 
Moreover, at 30 d post-implantation, all MSC groups 
showed high expression of proteoglycans with 
amounts similar to NHS.
Fig. 4. Picrosirius red histochemical analysis of NHS and HHS generated using ADSCs, DPSCs, WJSCs 
and BMSCs kept in vitro for 1, 2 and 4 weeks and grafted in vivo for 15 and 30 d. Scale bar: 200 µm. 
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Table 1. Semiquantitative analysis of ECM components, epithelial markers and HLA antigens in native 
and heterotypical bioengineered human skin. The well-organised collagen fibres of the ECM components 
are indicated by an asterisk. The staining reaction was categorised in each sample as strong (+++), mild (++), 
slight (+) or negative (–). For epithelial markers (CK5, CK10 and FGN), the positive expression was stated as 
basal layer (a), spinosum layer (b), granulosum layer (c), cornified layer (d) or all layers (e). § indicates that the 
expression was mainly detected at basal stratum, but it could be present with lower intensity in other strata.
In vitro In vivo











Collagen fibres +++ (*)
ADSCs - - - ++ ++
DPSCs - - - + +++(*)
WJSCs - - - +++(*) +++(*)
BMSCs - - - ++(*) +++(*)
GAG ++
ADSCs - - - - ++
DPSCs - - - - +
WJSCs - - - - +
BMSCs - - - - +
Proteoglycans +++
ADSCs - - - ++ +++
DPSCs - - - ++ +++
WJSCs - - - ++ +++










ADSCs - - - ++e ++e
DPSCs - - - ++e ++e
WJSCs - - +e ++a§ ++a§
BMSCs +e +e +e ++a§ ++a§
CK10 +++c,d
ADSCs - - - - +c
DPSCs - - - - +c
WJSCs - - +e ++c,d ++c,d
BMSCs - +e +e - ++c,d
Filaggrin +++d
ADSCs - - - +c,d ++c,d
DPSCs - - - +c,d ++c,d
WJSCs - - - +c,d +++d












l HLA I +++
ADSCs - - - - -
DPSCs - - - - -
WJSCs - - - - -
BMSCs - + + - -
HLA II ++
ADSCs - - - - -
DPSCs - - - - -
WJSCs - - - - -
BMSCs - - - + +
In vitro and in vivo expression of skin epithelial 
markers
CK5 expression was negative in vitro in ADSCs 
and DPSCs and positive in all layers after in vivo 
implantation. Moreover, WJSCs were slightly 
positive for CK5 expression after 4 weeks of in 
vitro development and signal notably increased 
after 15 and 30 d of implantation, resembling the 
expression pattern of native human skin – with 
positive expression mainly in the basal layer (Fig. 7, 
Table 1). Finally, BMSCs showed a slight expression 
of CK5 at 1, 2 and 4 weeks in all layers in vitro and 
mimicked the expression pattern of native human 
skin in vivo. The expression of CK10 in HHS samples 
was negative for ADSCs and DPSCs after 4 weeks of 
in vitro culture. Interestingly, a slight expression of 
CK10 was detected in all layers of BMSC samples after 
2 weeks of in vitro development and after 4 weeks 
in vivo. Similar expression levels were achieved in 
WJSCs after 4 weeks (Fig. 8, Table 1). Once grafted 
in vivo, WJSCs were the first MSC population able to 
generate epithelium-like cells expressing mild levels 
of CK10 in the cornified and granulosum layers 15 d 
post-implantation, which was maintained up to 30 d. 
At the end of the study, BMSCs and DPSCs showed 
a similar mild expression pattern of CK10, whereas 
ADSCs revealed a lower CK10 signal, confined to the 
granulosum layer.
 According to FGN expression, in vitro analysis 
did not show any sign of epithelial maturation (Fig. 
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Fig. 5. PAS histochemical analysis of NHS and HHS generated using ADSCs, DPSCs, WJSCs and 
BMSCs kept in vitro for 1, 2 and 4 weeks and grafted in vivo for 15 and 30 d. Scale bar: 200 µm. Black 
arrows point to GAGs in the basement membrane. 
Fig. 6. Alcian blue histochemical analysis of NHS and HHS generated using ADSCs, DPSCs, WJSCs 
and BMSCs kept in vitro for 1, 2 and 4 weeks and grafted in vivo for 15 and 30 d. Scale bar: 200 µm. 
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9, Table 1). Nonetheless, samples corresponding to 
ADSCs, DPSCs and WJSCs showed a slight FGN 
expression in cornified and granulosum layers after 
15 d of in vivo implantation and all samples had a 
mild expression after 30 d of in vivo grafting, except 
for WJSCs, which reached similar expression at the 
cornified layer mimicking NHS.
In vitro and in vivo immunogenical evaluation of 
HHS samples
The immunogenical potential of transdifferentiated 
MSCs was evaluated by the detection of HLA 
complex molecules. MSCs used to generate HHS 
models revealed low expression of HLA I molecules 
evaluated by immunohistochemistry in BMSCs and 
a lack of HLA II in all MSC groups in vitro. Once 
grafted, transdifferentiated MSCs were negative in 
all groups both at 15 and 30 d for HLA I. BMSCs 
showed a mild expression of HLA II after 15 and 30 d 
post-implantation (Fig. 10 and 11, Table 1).
Discussion
The skin is the largest organ of the human body. It 
serves as an effective barrier between the organism 
and the environment and is involved in the regulation 
of body temperature and fluid loss (Proksch et al., 
2008). Among the main conditions severely affecting 
the human skin, burns are serious therapeutical 
situations for which a fully valid management 
approach is not clinically available. In fact, treatment 
of deep burn-wounds is based on the use of 
autografts, which are not available in cases where 
large areas of skin are affected. Recently, tissue 
engineering has emerged as a therapeutic alternative, 
allowing the generation of autologous full-thickness 
skin substitutes for the treatment of deep burn-
wounds and showing promising results (Llames et 
al., 2004). Development of heterotypical artificial skin 
models would contribute to overcome the drawbacks 
associated with the generation of bioengineered skin.
 The use of MSCs as alternative cell sources offers 
several potential advantages such as availability, 
proliferation and differentiation capability with low 
immunogenic potential (Koppula et al., 2009; Weiss et 
al., 2008). The lack of immunological reaction makes 
these cells excellent candidates for cellular therapy 
in an allogeneic setting (Le Blanc and Ringden, 2005). 
However, a comparative study focussed on the 
differentiation potential of the four main sources of 
MSCs into skin epithelium has not been carried out 
to date. The present study approach was to determine 
the capability of each of the four MSC types to be 
induced using a specific epithelial conditioning 
medium in two-dimensional (2D) culture systems. 
Fig. 7. Immunofluorescent analysis of CK5 in NHS and HHS generated using ADSCs, DPSCs, WJSCs 
and BMSCs kept in vitro for 1, 2 and 4 weeks and grafted in vivo for 15 and 30 d. Scale bar: 200 µm. 
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Fig. 9. Immunofluorescent analysis of FGN in NHS and HHS generated using ADSCs, DPSCs, WJSCs 
and BMSCs kept in vitro for 1, 2 and 4 weeks and grafted in vivo for 15 and 30 d. Scale bar: 200 µm. 
Fig. 8. Immunofluorescent analysis of CK10 in NHS and HHS generated using ADSCs, DPSCs, WJSCs 
and BMSCs kept in vitro for 1, 2 and 4 weeks and grafted in vivo for 15 and 30 d. Scale bar: 200 µm. 
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Results showed a small number of induced genes. 
ADSCs and WJSCs showed larger percentages of 
induced genes. However, BMSCs and DPSCs were 
able to induce a series of genes with a putative role 
in epithelial cell function, such as cell adhesion. 
These results supported the use of the four MSC 
types in tissue engineering, given their epithelial 
differentiation capability, as previously demonstrated 
(Zhang et al., 2012). In the present work, novel models 
of bioengineered skin generated by using four MSC 
types were described. In agreement with previous 
reports, suggesting that heterotypical bioengineered 
tissues have low levels of differentiation while kept 
in vitro (Garzon et al., 2013; Garzon et al., 2009a), in 
vitro tissues had very few cell layers on top of the 
dermis substitute – although the number of cell layers 
tended to increase with time – and a complete absence 
of differentiation markers, such as rete ridges and 
chorial papillae or keratinisation.
 Expression of CK is one of the main features of 
human epidermal cells. For this reason, the first 
CK analysed was CK5, which is paired with CK14 
and is a marker of basal proliferative keratinocytes 
that act as epithelial stem cells (Kim et al., 2002). 
Results showed that WJSCs and BMSCs were able 
to express small amounts of this marker under in 
vitro conditions, suggesting that these cell types 
could respond to epithelial inductive medium more 
efficiently than ADSCs and DPSCs. However, the 
in vivo setting was able to induce the expression of 
CK5 in all samples, but the expression pattern tended 
to resemble the preferentially basal expression of 
native skin only in the two cell types that showed the 
highest differentiation potential in vitro, WJSCs and 
BMSCs. On the other hand, HHS generated using 
WJSCs and BMSCs showed mild expression of CK10 
in most epithelial-like cells. The slight expression of 
CK10 under in vitro conditions could be linked to an 
early epithelial differentiation stage. However, when 
tissue samples were implanted in vivo, differentiation 
was enhanced and stratification organisation was 
more evident. The proper set-up of basal cells may 
enhance proliferation and cell differentiation into 
epithelial-like tissue. An interesting phenomenon 
was that BMSCs showed slight CK10 expression in 
vitro, but this expression was initially negative in 
vivo and became positive at 30 d. This finding may 
be explained as an adaptive process of the cells, 
which could partially lose their original orientation 
in vivo and, thus, minimise their expression profile 
until the epithelium became fully differentiated. 
These results, related to the in vitro differentiation 
potential of WJSCs and BMSCs, were in agreement 
with previous work demonstrating their keratinocytic 
differentiation capability (Garzon et al., 2013) and 
with the fact that ADSCs and DPSCs have not yet 
been differentiated into skin keratinocytes – although 
reports have suggested that these cell types may have 
epithelial differentiation capability in the presence 
of inductive medium (Baer et al., 2013; Dogan et al., 
Fig. 10. Immunohistochemistry analysis of HLA I in NHS and HHS generated using ADSCs, DPSCs, 
WJSCs and BMSCs kept in vitro for 1, 2 and 4 weeks and grafted in vivo for 15 and 30 d. Scale bar: 200 µm. 
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Fig. 11. Immunohistochemistry analysis of HLA II in NHS and HHS generated using ADSCs, DPSCs, 
WJSCs and BMSCs kept in vitro for 1, 2 and 4 weeks and grafted in vivo for 15 and 30 d. Scale bar: 200 µm. 
2015). In the present study, both WJSCs and BMSCs 
were able to develop a larger number of cell layers 
at the in vitro stage, which coincided with the early 
cytokeratin expression. Therefore, the use of a 
combined trans-differentiation protocol based on 
epithelial conditioning medium, 3D systems with 
dermal cells supporting epithelial-mesenchymal 
interaction and air-liquid culture technique could 
partially induce in vitro epidermal differentiation of 
some of the studied MSC types but failed to achieve 
terminal differentiation.
 In vivo grafting was performed by using a 
plastic ring standardised model (Fang and Mustoe, 
2008; Galiano et al., 2004) to minimise and control 
wound contraction. Previous studies have described 
contraction in mice as a common physiological 
phenomenon after skin grafting. Park et al. (2014) 
compared the use of splinted versus non-splinted 
models and demonstrated that the wound generated 
in the skin of the animal tends to fully shrink and 
contract after 11 d in non-splinted models, whereas 
splinted models reduce the contraction rate to near 
60 % after 11 d (Gebremeskel et al., 2018; Park et al., 
2014). In the present study, the wound contraction 
percentage reached 61.7 % after 30 d, suggesting a 
reduction of the wound contraction that may improve 
re-epithelisation with the grafted tissue. These results 
are in accordance with a study reporting that use of 
silicone splints around dorsal wounds may attenuate 
contraction but that the final graft size is typically 
around 40-50 % (Galiano et al., 2004).
 Once grafted in vivo, MSCs were subjected to 
additional differentiation signals depending on the 
local and systemic inductive factors generated by 
the host. This resulted in higher differentiation in all 
cases, with the formation of terminally differentiated 
epithelial cell layers and other differentiation 
markers. Previous reports have demonstrated that 
the in vivo environment is necessary for the cells 
to fully develop and differentiate, which does not 
occur in vitro (Garzon et al., 2009a; Garzon et al., 
2013). One of the challenges of bioartificial tissues 
grafted in immunodeficient animals is demonstrating 
the presence of the human cells in the graft and 
determining the fate of the implanted cells. In the 
present work, human-specific antibodies were used 
to demonstrate that cells in the regenerated skin 
area were of human nature. Future studies should 
analyse cell migration and stability in vivo by using 
high-definition cell-tracking techniques (Bulte and 
Daldrup-Link, 2018).
 The in vitro analysis of the dermal substitute 
showed a complete absence of the fibrillar and non-
fibrillar ECM components analysed, which tended to 
appear in vivo. In general, the artificial dermis grafted 
in vivo was able to synthesise and generate abundant 
amounts of collagen fibres and reached the levels of 
the control except for ADSCs, suggesting that the type 
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of MSCs used as epithelial substitute may influence 
the biosynthetic activity of dermal fibroblasts. The 
presence of collagen fibres is very important to keep 
the biomechanical properties of the human skin 
(Aziz et al., 2016) and its presence in the dermal 
substitute could favour the adequate physiology and 
mechanical behaviour of the artificial skin. In this 
regard, the fibrin-agarose bioartificial human tissue 
substitutes share some biomechanical similarities 
[G’ modulus ranging between 30 and 70 Pa and G’’ 
between 40 and 50 Pa (Rodriguez et al., 2012)] with 
native human tissues, although their biomechanical 
properties are not completely biomimetic to control 
tissues.
 Regarding the non-fibrillar ECM components of 
the dermal substitute, results showed that the four 
types of HHC were able to synthesise GAGs, although 
only ADSCs were able to reach the expression levels 
found in the control tissues. However, proteoglycans 
were very abundant in the four MSC types after 30 d of 
development, suggesting that this important dermal 
component was easily generated by the dermal 
fibroblasts independently of the type of epithelial 
substitute found on top. Previous work showed that 
GAGs and proteoglycans are important components 
of the skin ECM that may facilitate wound healing, 
cell adhesion, migration, proliferation, metabolism, 
differentiation, survival and growth factor activity 
(Ghatak et al., 2015). Therefore, their presence in the 
bioengineered skin should be a requisite for these 
tissues to be clinically useful and previous fibrin-
agarose human bioartificial skin models display 
high expression of these components in vivo (Martin-
Piedra et al., 2017).
 Results of the epithelial substitute showed 
that the highest epithelial differentiation potential 
corresponded to WJSCs and BMSCs according to 
CK10 expression and WJSCs according to FGN. 
Along with the larger number of cell layers in WJSC-
based HHS, these findings would confirm previous 
results showing the skin-epithelium differentiation 
potential of WJSCs (Garzon et al., 2013). In contrast 
with the other three MSC types studied, WJSCs 
were obtained from new-born umbilical cords. 
This perinatal cell source could retain some of 
the proliferation and differentiation capabilities 
of embryonic cells, which could explain their 
potential in tissue regeneration. WJSCs are easily 
accessible and have been extensively used in tissue 
engineering and regenerative medicine without the 
risk of tumorigenesis (Joerger-Messerli et al., 2016). 
However, the other three MSC types also displayed 
differentiation potential as epithelial markers, as 
determined by CK10 and FGN expression analysis, 
and showed high expression of proteoglycans and 
collagen (especially DPSCs and BMSCs). Future 
works should determine if these four MSC types 
may have the potential to fully differentiate into skin 
epidermis by using other inductive factors or clues, 
other in vivo models or longer follow-up periods.
 One possible issue related to the use of 
MSCs differentiated towards human epithelial 
keratinocytes is the possibility that immunopriviliged 
undifferentiated MSCs (Weiss et al., 2008) might 
acquire immunogenicity under certain conditions, 
including epidermal differentiation. In fact, 
upregulation of major histocompatibility complex 
(MHC)-II antigens is detected after gamma-interferon 
induction in MSC cultures, which could point 
towards this possibility (Le Blanc and Ringden, 
2005). In the present work, the four analysed MSC 
types were initially negative for several HLA I and 
HLA II markers in the HHS models. However, 
preliminary epithelial differentiation found in BMSC-
HHS kept in vitro for 2 and 4 weeks (as determined 
by CK10 immunostaining) coincided with a slight 
expression of HLA I antigens. Nevertheless, in vivo 
grafting resulted in a complete absence of HLA I 
signal in all HHS types, although HLA II became 
slightly positive in BMSC-HHS after 15 and 30 d 
of in vivo development. The transient expression of 
HLA I in BMSCs kept in vitro remains intriguing 
and future studies should be performed to elucidate 
this issue. One important concern is the possibility 
that HHS cells could express HLA markers after full 
differentiation, as previously suggested for bone and 
cartilage tissue substitutes (Lee et al., 2012; Lohan et 
al., 2014; Lohan et al., 2017). The lack of information 
related to HLA expression on MSCs differentiated 
towards epithelial cell lineages makes necessary to 
perform future studies using longer follow-up times.
 Altogether, these results confirm the absence 
of immunogenic HLA markers in bioengineered 
human substitutes generated using ADSCs, DPSCs 
and WJSCs. Although the epithelial layer was 
differentiated and would support the future clinical 
use of these substitutes, BMSC-based HHS could 
become immunogenic for HLA II upon induction. 
For this reason, the preferential use of HHS based 
on ADSCs, DPSCs and WJSCs instead of BMSCs 
would be recommendable. Therefore, these results 
would support the use of these types of MSCs for the 
generation of heterotypical models of human skin, 
but also other bioengineered tissues or organs such 
as human cornea and oral mucosa.
 For the clinical transference of these bioengineered 
skin substitutes, several steps should be achieved, 
including exhaustive preclinical quality control 
analyses fulfilling the requirements of the European 
Medicines Agency.
Conclusions
Results demonstrated the partial epithelial 
differentiation capability of ADSCs, DPSCs, WJSCs 
and BMSCs, which could be used for the generation of 
bioengineered human skin substitutes with potential 
clinical usefulness. However, WJSCs demonstrated 
the highest differentiation capability and lack of HLA 
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I and II expression upon induction. Therefore, WJSCs 
could be used for the generation of human skin 
substitutes. However, future studies should assess the 
functional properties of the skin regenerated by these 
substitutes and its long-term differentiation potential.
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Discussion with Reviewer
Reviewer: What are next steps for the development 
of this bioengineered skin substitute to obtain an 
epidermis similar to human skin with terminally 
differentiated epithelial cell layers on the entire 
surface?
Authors: The promising results of the study lead to 
the hypothesis that the HHS generated could have 
future clinical translation potential. Therefore, next 
steps should include fulfilling the requirements 
of the European Medicines Agency for Advanced 
Therapies, including the preclinical characterisation 
at the biomechanical, physiological and optical (UV 
absorbance, speckle pattern) levels. In addition, 
improving the current HHS model by incorporating 
vascular progenitors in order to achieve vascularised 
models is in progress.
Reviewer: Several studies have shown the re-
expression of HLA upon differentiation of stem 
cells (Lee et al., 2012; Lohan et al., 2014). Could the 
authors comment on the possibility that HLA could 
be re-expressed when the epidermis will be fully 
differentiated?
Authors: This is an important issue as HHS cells 
could express HLA markers after full differentiation, 
as described for bone and cartilage tissue substitutes 
(Lee et al., 2012; Lohan et al., 2014; Lohan et al., 2017). 
However, the lack of information related to HLA 
expression on epithelial differentiation of MSCs point 
out the importance to perform further research in 
this field.
Editor’s note: The Scientific Editor responsible for 
this paper was Mauro Alini.
